PT733370E - Utilizacao da sequencia de um promotor genico para o tratamento de doencas reumaticas - Google Patents

Utilizacao da sequencia de um promotor genico para o tratamento de doencas reumaticas

Info

Publication number
PT733370E
PT733370E PT93923675T PT93923675T PT733370E PT 733370 E PT733370 E PT 733370E PT 93923675 T PT93923675 T PT 93923675T PT 93923675 T PT93923675 T PT 93923675T PT 733370 E PT733370 E PT 733370E
Authority
PT
Portugal
Prior art keywords
utilization
sequence
treatment
rheumatic diseases
genetic promoter
Prior art date
Application number
PT93923675T
Other languages
English (en)
Inventor
Shunichi Shiozawa
Original Assignee
Shunichi Shiozawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shunichi Shiozawa filed Critical Shunichi Shiozawa
Publication of PT733370E publication Critical patent/PT733370E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/13—Decoys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT93923675T 1993-10-29 1993-10-29 Utilizacao da sequencia de um promotor genico para o tratamento de doencas reumaticas PT733370E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1993/001581 WO1995011684A1 (fr) 1993-10-29 1993-10-29 Inhibiteur antagoniste de la croissance des cellules mesenchymateuses

Publications (1)

Publication Number Publication Date
PT733370E true PT733370E (pt) 2003-07-31

Family

ID=14070618

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93923675T PT733370E (pt) 1993-10-29 1993-10-29 Utilizacao da sequencia de um promotor genico para o tratamento de doencas reumaticas

Country Status (10)

Country Link
EP (1) EP0733370B1 (pt)
KR (1) KR100306376B1 (pt)
AT (1) ATE232731T1 (pt)
AU (1) AU683626B2 (pt)
CA (1) CA2175368C (pt)
DE (1) DE69332702T2 (pt)
DK (1) DK0733370T3 (pt)
ES (1) ES2188597T3 (pt)
PT (1) PT733370E (pt)
WO (1) WO1995011684A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1350514A3 (en) 1993-10-29 2004-07-07 The Brigham And Women's Hospital, Inc. Therapeutic use of cis-element decoys in vivo
US7615538B2 (en) * 1993-10-29 2009-11-10 Shunichi Shiozawa Method for therapy of rheumatoid arthritis
CA2300328A1 (en) 1999-09-14 2001-03-14 Cardiogene Gentherap. Systeme Ag Modulating transcription of genes in vascular cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991006570A1 (en) * 1989-10-25 1991-05-16 The University Of Melbourne HYBRID Fc RECEPTOR MOLECULES
WO1991011535A1 (en) * 1990-01-30 1991-08-08 Childrens Hospital Of Los Angeles Inhibition of transcription by double-stranded oligonucleotides
JPH06502532A (ja) * 1990-10-10 1994-03-24 ラ　ジョラ　キャンサー　リサーチ　ファウンデーション 核受容体を用いた転写抑制の方法
WO1992018522A1 (en) * 1991-04-18 1992-10-29 The Salk Institute For Biological Studies Oligodeoxynucleotides and oligonucleotides useful as decoys for proteins which selectively bind to defined dna sequences
AU3584993A (en) * 1992-01-27 1993-09-01 Trustees Of The University Of Pennsylvania, The Methods and compositions for neutralizing intracellular nucleic acid-binding protein biological activity in a cell, including methods and compositions useful to regulate gene function

Also Published As

Publication number Publication date
DE69332702D1 (de) 2003-03-27
WO1995011684A1 (fr) 1995-05-04
KR960705576A (ko) 1996-11-08
AU683626B2 (en) 1997-11-20
KR100306376B1 (ko) 2001-11-30
EP0733370A4 (en) 1999-12-29
EP0733370B1 (en) 2003-02-19
DE69332702T2 (de) 2003-10-16
AU5345294A (en) 1995-05-22
CA2175368A1 (en) 1995-05-04
ES2188597T3 (es) 2003-07-01
ATE232731T1 (de) 2003-03-15
EP0733370A1 (en) 1996-09-25
DK0733370T3 (da) 2003-04-07
CA2175368C (en) 2004-07-20

Similar Documents

Publication Publication Date Title
DE69434663D1 (de) Nukleotid-sequenzen zur kontrolle der exprimierung von dns-sequenzen in einem zellulärem wirt
DE69434209D1 (de) REGULATION DER GENEXPRESSION VON bcl-2
GB2348424B (en) Regulation of endogenous gene expression in cells using zinc finger proteins
ES2127831T3 (es) Unidades de expresion multicistronicas y su aplicacion.
PT695360E (pt) Adenovirus recombinantes deficientes, para a terapia genica de tumores
DK0556345T3 (da) Retrovirale vektorer,som er egnede til genterapi
PT1411118E (pt) Inibidores da proliferação celular contendo um anticorpo anti-glipicano 3
DE69434312D1 (de) Regulierung von pflanzenwachstum
DE69227392T2 (de) Serumfreies Medium zur Züchtung von Tierzellen
ATE113656T1 (de) Hühner-beta-actin-genpromoter enthaltender vektor zur expression eines erwünschten gens.
NO910982L (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
PT94680A (pt) Processo para a obtencao de uma proteina tendo actividade de urato oxidase gene recombinante que a codifica vector de expressao portador deste gene microorganismos procariotas e celulas eucariotas transformados por este vector de expressao
AU613770B2 (en) Nucleotide sequence encoding plant ribosome inactivating protein
PT733370E (pt) Utilizacao da sequencia de um promotor genico para o tratamento de doencas reumaticas
ATE310082T1 (de) Pflanzenpromoter und dessen verwendung zur genexpression
ES2136199T3 (es) Expresion multicistronica de genes recombinantes en celulas bacterianas.
ITMI931034A1 (it) Processo per la preparazione di proteine inibenti i ribosomi
ITMI921476A0 (it) Sequenze nucleotidiche codificati proteine vegetali inattivati i ribosomi
BR1100404A (pt) Gene recombianante para uma expressão nas células eucarióticas de uma proteìna tal como a urato oxidase
ES2140307A1 (es) Acidos nucleicos reguladores de la expresion genica.